Refractory Osteosarcoma: Clinical Trials

1 trial for Refractory Osteosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1

Follow Refractory Osteosarcoma: new trials by email Literature Review of Refractory Osteosarcoma trials Research Report on Refractory Osteosarcoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma
IM83 CAR-T Cells - Refractory Osteosarcoma, Recurrent Osteosarcoma
Phase 1UnknownBeijing Immunochina Medical Science & Technology Co., Ltd.92024-06-152024-05-14

Narrower conditions

Osteosarcoma (1)  ·  Recurrence (1)

Broader conditions

Disease Attributes (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Bone Tissue (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sarcoma (1)

Sponsors

Beijing Immunochina Medical Science & Technology Co., Ltd. (1)

Countries

China (1)

Top investigators

Yu Zhang, PhD (1)